{"url_path":"/sec/govx/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 ******","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/832489/0001437749-26-017048-index.html","accession_number":"0001437749-26-017048","cik":"0000832489","ticker":"GOVX","issuer_name":"GeoVax Labs, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/832489/0001437749-26-017048-index.html","primary_entity_key":"0000832489","primary_entity_name":"GeoVax Labs, Inc."},"word_count":94,"has_tables":true,"body_markdown":"**Item 5******\n\n**Other Information**\n\n \n\nDuring the period covered by this report, none of our directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408(a) of Regulation S-K).\n\n \n\nDuring the period covered by this report, there was no information required to be disclosed by us in a Current Report on Form 8-K that was not so reported, nor were there any material changes to the procedures by which our security holders may recommend nominees to our board of directors.\n\n \n\n16"}